Packaging & Product Protection White Papers & Case Studies

  1. Demonstrating Compliance With Pharmaceutical Industry Leachability Requirements

    Details of the research and results that has allowed a pharmaceutical serialization company and CMO to confidently conclude that there is no ink migration of inks through the walls of the HDPE bottles.

  2. Smart Manufacturing Solutions Drive Digital Transformation in Life Sciences

    Innovative companies are now applying industry-specific Smart Manufacturing solutions to reduce time to value and improve efficiency and asset utilization while ensuring product and data integrity, regulatory compliance and safety.

  3. Customized Coding and Automation Systems For Pharma Compliance

    R+D Custom Automation partners with Domino to brainstorm tailored coding solutions for each challenge created by the development of their client’s custom machines for the life sciences industries.

  4. Medical Device Labeling — Regulations In The U.S., EU, And China

    While there are a certain amount of commonalities in regulations in each country, there are differences which necessitate care from global manufacturers when distributing products.

  5. Ensuring Pharmaceutical Film Strength To Avoid Damaged Product

    This method can be used to identify potential points of weakness in a film or seal during the manufacturing process by simulating circumstances whereby the material may burst during packaging and transport.

  6. Evaluating Inhaler Performance To Ensure Clinical Efficacy

    MDIs are designed to deliver precise/accurate and reproducible doses of the drug to the lungs or nose. Good performance is crucial as patients rely on their inhaler to deliver the required dose of medication at often crucial times.

  7. Measuring The Hardness Of Blister Packs To Determine Effectiveness

    The degree of stiffness of a blister pack will affect its effectiveness. Measuring the required force to push-through a blister pack is therefore necessary.

  8. Beyond Item-Level Serialization: Extending Traceability Schemes To Secondary And Tertiary Packaging

    Falsified and counterfeit medicines are a chronic problem for the pharmaceutical sector, with a third of all shipments in the worst affected parts of the world estimated to contain fake medicines.

  9. The Hidden Challenges Of Pharmaceutical Serialization

    The true extent of the counterfeiting is unknown, since no global study has ever been carried out, but according to WHO estimates, up to 15% of all medicines are counterfeit.

  10. The EU Falsified Medicines Directive – Concerted Action To Secure The pharmaceutical supply Chain

    In recent years the production of, and trade in, falsified medicines – both research based and generic – has grown to become a global illegal business. At the borders of the EU alone over 30 million counterfeit medicines have been seized during the last five years, and the statistics regarding medicines supplied online are equally disturbing: according to the European Alliance for Safe Medicines, 62% of medicines purchased online are fake or substandard.